Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus — Stella

Recruiting

Back to Type 2 Diabetes trials

Trial locations(2 sites)

Netherlands

Amsterdam University Medical Centers, Amsterdam

Cardiology Centers of the Netherlands, Amsterdam

Key details

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborators

Horizon Innovative Health Initiative, Novo Nordisk A/S

Enrollment target

~1,000 participants

Started

June 2025

Primary completion

October 2026

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov